Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis?
Authors:
- 19 July 2021
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 21 (8) , 837-841
Abstract
Multiple sclerosis (MS) is a chronic inflammatory, demyelinating and neurodegenerative disease of the central nervous system (CNS) characterized by the accumulation of focal white matter (WM) lesio...Keywords
This publication has 17 references indexed in Scilit:
- Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesionsMultiple Sclerosis Journal, 2018
- Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesionsBrain, 2018
- Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imagingPLOS ONE, 2018
- Positron emission tomography imaging in evaluation of MS pathology in vivoMultiple Sclerosis Journal, 2018
- Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysisActa Neuropathologica, 2018
- Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple SclerosisJournal of Nuclear Medicine, 2017
- Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imagingActa Neuropathologica, 2016
- Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesionsJournal of Clinical Investigation, 2016
- Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaqueAnnals of Neurology, 2015
- Seven‐tesla phase imaging of acute multiple sclerosis lesions: A new window into the inflammatory processAnnals of Neurology, 2013